Skip to Content

How does Lutathera work to treat gastroenteropancreatic neuroendocrine tumors?

Answers (1)

Official Answer by 7 Mar 2018

Lutathera (lutetium Lu 177 dotatate), a Lu-177-labeled somatostatin analogue, is a radioactive drug that binds to a somatostatin receptor on the gastroenteropancreatic neuroendocrine tumor to exert its cancer-killing effect. The FDA approved Lutathera for the treatment of somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in January 2018. GEP-NETs are rare cancers that form in the pancreas, stomach, intestines, colon and rectum. free discount card

Further Information

Search for questions

Still looking for answers? Try searching for what you seek or ask your own question.

Frequently Asked Questions

What type of drug is Motegrity?

Updated 18 days ago 1 answerFAQ by

What disease is Elzonris (tagraxofusp-erzs) used to treat?

Updated 15 days ago 1 answerFAQ by

How do you use the ProAir Digihaler?

Updated 15 days ago 1 answerFAQ by

How many biosimilars have been approved in the United States?

Updated 14 days ago 1 answerFAQ by